DBV TECHNOLOGIES |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.212 EUR | +0.33% |
|
-4.57% | -34.45% |
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Sector
Pharmaceuticals
Calendar
2024-05-01
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
1.212
EUR
Average target price
4.783
EUR
Spread / Average Target
+294.66%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -34.45% | 125M | |
| +5.73% | 70.78B | |
| +11.81% | 9.15B | |
| -15.34% | 4.84B | |
| +34.54% | 4.22B | |
| +5.09% | 3.92B | |
| +27.76% | 2.55B | |
| -28.33% | 2.24B | |
| -24.15% | 2.26B | |
| +6.23% | 1.92B |
- Stock Market
- Equities
- DBV Stock
- Funds and ETFs DBV Technologies
